Tirzepatide 20mg

tirzepatide 20mg research peptide uk — supplied as a high-purity lyophilized powder for laboratory research use only. Each vial is independently tested by third-party analytical verification (COA available) to confirm identity and purity. This product is intended only for qualified researchers in controlled laboratory environments.

Tirzepatide is a synthetic peptide studied for its activity as a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. Preclinical investigations explore its role in glucose metabolism, insulin sensitivity, and energy balance. Researchers also study its effects on satiety and appetite regulation in metabolic research models.

In experimental studies, tirzepatide 20mg research peptide uk has been evaluated for its potential to influence body weight, glycemic control, and lipid metabolism. Laboratory work often examines how dual receptor targeting may provide insights into endocrine signaling and metabolic adaptation. Findings remain preclinical and are not intended for therapeutic application.

This peptide is not for human or veterinary use and must not be used in diagnostic or clinical settings. Researchers should handle material with protective laboratory equipment, reconstitute only in sterile solvents, and store vials under recommended conditions.

This listing provides tirzepatide 20mg research peptide uk with COA; supplied for research purposes only; not for human or veterinary consumption; UK supply only to qualified laboratories.